Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

Alessandro Armuzzi, A. Lewis, J. O. Lindsay, A. Silver

Risultato della ricerca: Contributo in rivistaArticolo in rivista

69 Citazioni (Scopus)

Abstract

A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).
Lingua originaleEnglish
pagine (da-a)26-38
Numero di pagine13
RivistaALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume41
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • inflammatory bowel disease
  • therapeutic targets

Fingerprint

Entra nei temi di ricerca di 'Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases'. Insieme formano una fingerprint unica.

Cita questo